Pharmaceutical probiotics based on SF68® have a long history of safe use and proven efficacy in the prevention and treatment of intestinal disorders.
Cerbios has long-term customers receiving products based on Enterococcus faecium SF68® (SF68®) in different forms of standardized active ingredients, intermediates and finished products, such as hard gelatin capsules in glass bottles. Licensing opportunities for several markets are available.
SF68® is considered one of the best characterized probiotic active ingredients for the prevention and treatment of intestinal disorders. The pharmacological properties and safety profile of SF68® have been extensively studied. The efficacy of SF68® has been confirmed in many double blind clinical trials.